GlassScriptPhysician profile
Darlene M Bugoci
NPI 1295980308
$1,782.94
in general payments reported to CMS, 2019-2025
14 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $742 · 2022: $20.08 · 2023: $430 · 2024: $345 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zap Surgical Systems, INC. | $615.66 | 2021 | |
| Novocure INC. | $364.07 | 2021-2025 | Optune, Optune Lua (Novottf-200t) |
| Siemens Medical Solutions USA, INC. | $335.70 | 2021-2024 | Varian Treatment, Varian Ethos Treatment Planning, Aria Radiation Therapy Management Software |
| Sumitomo Pharma America, INC. | $183.98 | 2023-2025 | Orgovyx |
| Monteris Medical Corporation | $50.56 | 2023-2024 | Neuroblate |
| Merck Sharp & Dohme LLC | $43.67 | 2024-2025 | Keytruda |
| Lilly USA, LLC | $31.73 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.15 | 2024 | |
| Tactile Systems Technology INC | $24.50 | 2025 | Nimbl, Flexitouch Plus |
| Janssen Biotech, INC. | $21.64 | 2021 | |
| Sobi, INC | $21.29 | 2025 | |
| Ambu INC. | $20.33 | 2023 | |
| Myovant Sciences INC. | $20.08 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlene Bugoci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.